Showing results (391-400 of 1,453) with videos related to

Sort By:
Pageof 146
American Journal of Medical Genetics|July 23, 1998
Analysis of the genomic structure of the human glycine receptor alpha2 subunit gene and exclusion of this gene as a candidate for Rett syndromeC J Cummings, E J Dahle, H Y Zoghbi
Gene|October 1, 1980
Cloning and characterization of Paramecium mitochondrial DNA replication initiation regionsA E Pritchard, L M Herron, D J Cummings
Bulletin of Mathematical Biology|February 3, 2012
Analysis of Biochemical Equilibria Relevant to the Immune Response: Finding the Dissociation ConstantsL J Cummings, R Perez-Castillejos, E T Mack
Neurology|January 10, 2001
Cardiovascular risk factors and cognitive decline in middle-aged adultsD Knopman, L L Boland, T Mosley, et al.
The Journal of Prevention of Alzheimer'S Disease|May 11, 2022
Therapeutic Targets for Alzheimer's Disease: Amyloid Vs. Non-Amyloid. Where Does Consensus Lie Today? An CTAD Task Force ReportS Gauthier, A Boxer, D Knopman, et al.
The Journal of Pharmacy and Pharmacology|January 1, 1993
The long term stability of mechlorethamine hydrochloride (nitrogen mustard) ointment measured by HPLCJ Cummings, A MacLellan, S J Langdon, et al.
Analytical Biochemistry|September 25, 2001
High-performance liquid chromatographic technique for the simultaneous determination of lactone and hydroxy acid forms of camptothecin and SN-38 in tissue culture media and cancer cellsG Boyd, J F Smyth, D I Jodrell, et al.
Biochemical Pharmacology|June 22, 1993
Correlation between tumour drug disposition and the antitumour activity of doxorubicin-loaded microspheres: implications for the drugs' in vivo mechanism of actionJ Cummings, N Willmott, E C Marley, et al.
Anti-Cancer Drug Design|July 1, 1996
Characterization of the major metabolite of the novel topoisomerase I inhibitor NU/ICRF 505J Cummings, I Meikle, J S Macpherson, et al.
British Journal of Cancer|August 1, 1996
Induction of apoptosis in human cancer cell lines by the novel anthracenyl-amino acid topoisomerase I inhibitor NU/ICRF 505I Meikle, J Cummings, J S Macpherson, et al.
Pageof 146